Source linked

New Decision-Support Tool Bridges Pediatric Eye Care Specialist Shortage

The Amblyopia Navigator Decision-Support Instrument (ANDI) uses data from 147 studies to guide general clinicians through complex pediatric vision management.

nihpedigoregon health science universityjules stein instituteamblyopiabiotech health

Three out of every 100 children in the United States suffer from amblyopia, a condition where the brain fails to develop normal vision in one or both eyes. If left untreated during early childhood, this vision loss becomes permanent, resisting all forms of adult correction via glasses or contact lenses.

Closing the Geographic Gap in Specialist Access

Recent workforce studies reveal a massive imbalance in how pediatric optometrists and ophthalmologists are distributed across the U.S., with specialists clustering in specific states while leaving others with zero coverage. To combat this, the Pediatric Eye Disease Investigator Group (PEDIG) has launched the Amblyopia Navigator Decision-Support Instrument (ANDI).

Developed by an NIH-funded network of over 400 investigators, ANDI functions as an open-access clinical guide. It allows general eye doctors without specialized pediatric training to navigate the complexities of diagnosis and management. The tool distills evidence from 147 published studies into actionable advice, even providing article figures that can serve as physical reference sheets for clinicians without reliable internet access.

Automated Management of Complex Vision Pathways

Once a diagnosis is confirmed, ANDI guides the clinician through a tiered treatment hierarchy. The instrument helps determine the optimal glasses prescription and calculates how long a patient should be monitored to see if vision improves through correction alone—a strategy that works for up to one-third of children.

If glasses prove insufficient, the tool walks the doctor through advanced interventions, including:

  • Patching the stronger eye for specific daily durations
  • Using atropine eye drops to induce temporary blurring
  • Implementing newer digital treatments via specialized games or videos

When progress stalls, the system advises whether to increase treatment intensity, switch modalities, or refer the patient to a specialist. By providing clear follow-up protocols and signs of recurrence, ANDI enables more consistent care in underserved regions. This deployment of evidence-based decision support marks a shift toward decentralized, high-precision pediatric ophthalmic care.


Source: NIH-supported project expands access to care for children with amblyopia
Domain: nih.gov

Read original source ->

External source stays available while the OJO article and comment thread stay local.

Comments load interactively on the live page.